Manufacturer of Controlled Substances; Notice of Application, 35310-35311 [E6-9508]
Download as PDF
<![CDATA[
35310
Federal Register / Vol. 71, No. 117 / Monday, June 19, 2006 / Notices
including public filing with a court, to the
extent that disclosure of the information is
relevant and necessary to the litigation or
discussions and except where court orders
are otherwise required under section (b)(11)
of the Privacy Act of 1974, 5 U.S.C.
552a(b)(11).
L. Disclosure to Labor Unions
Information from this system of records
may be disclosed to provide information to
officials of labor organizations when relevant
and necessary to their duties of exclusive
representation concerning personnel policies,
practices, and matters affecting work
conditions.
jlentini on PROD1PC65 with NOTICES
Appendix B: Government-Wide
Systems Notices Applicable to the
Commission
The Commission maintains some records
covered by Government-wide systems of
records notices published by other agencies.
There may not be actual Commission files in
all Government-wide systems. This list is
based on Privacy Act Issuances, 2003
Compilation, available at https://
www.gpoaccess.gov/privacyact/2003.html.
Any later established Government-wide
systems notices may also be applicable.
1. DOL/GOVT–1 Federal Employees’
Compensation Act File.
2. DOL/GOVT–2 Jobs Corps Student
Records.
3. EEOC/GOVT–1 Equal Employment
Opportunity in the Federal Government
Complaint and Appeal Records.
4. FEMA/GOVT–1 National Defense
Executive Reserve System.
5. GSA/GOVT–2 Employment Under
Commercial Activities Contracts.
6. GSA/GOVT–3 Travel Charge Card
Program.
7. GSA/GOVT–4 Contracted Travel Service
Program.
8. GSA/GOVT–5 Access Certificates for
Electronic Services.
9. MSPB/GOVT–1 Appeals and Case
Records.
10. OGE/GOVT–1 Executive Branch
Personnel Public Financial Disclosure
Reports and Other Name-Retrieved Ethics
Program Records.
11. OGE/GOVT–2 Executive Branch
Confidential Financial Disclosure Reports.
12. OPM/Central–1 Civil Service
Retirement and Insurance Records.
13. OPM/Central–2 Complaints and
Inquiries Records.
14. OPM/Central–5 Intergovernmental
Personnel Act Assignment Records.
15. OPM/Central–6 Administrative Law
Judge Application Records.
16. OPM/Central–7 Litigation and Claims
Records.
17. OPM/Central–9 Personnel
Investigations Records.
18. OPM/Central–10 Federal Executive
Institute Program Participant Records.
19. OPM/Central–11 Presidential
Management Intern (PMI) Program Records.
20. OPM/Central–13 Executive Personnel
Records.
21. OPM/GOVT–1 General Personnel
Records.
22. OPM/GOVT–2 Employee Performance
File System Records.
VerDate Aug<31>2005
16:46 Jun 16, 2006
Jkt 208001
23. OPM/GOVT–3 Records of Adverse
Actions, Performance Based Reduction in
Grade and Removal Actions, and
Termination of Probationers.
24. OPM/GOVT–5 Recruiting, Examining,
and Placement Records.
25. OPM/GOVT–6 Personnel Research and
Test Validation Records.
26. OPM/GOVT–7 Applicant Race, Sex,
National Origin, and Disability Status
Records.
27. OPM/GOVT–9 File on Position
Classification Appeals, Job Grading Appeals,
and Retained Grade or Pay Appeals, and Fair
Labor Standard Act (FLSA) Claims and
Complaints.
28. OPM/GOVT–10 Employee Medical File
System Records.
Issued: June 13, 2006.
By order of the Commission.
Marilyn R. Abbott,
Secretary to the Commission.
[FR Doc. 06–5523 Filed 6–16–06; 8:45 am]
BILLING CODE 7020–02–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on January
20, 2006, Aptuit, 10245 Hickman Mills
Drive, Kansas City, Missouri 64137,
made application by letter to the Drug
Enforcement Administration (DEA) for
registration as an importer of a Cocaine
derivative under the drug code for
Cocaine (9041), a basic class of
controlled substance in Schedule II.
The company plans to import bulk
capsules in dosage form specifically for
packaging for a clinical trial study.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than July 19, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 301.34(b), (c), (d), (e) and (f) are
satisfied.
Dated: June 12, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–9511 Filed 6–16–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to section 1301.33(a) of Title
21 of the Code of Federal Regulations
(CFR), this is notice that on May 11,
2005, Cedarburg Pharmaceutical, Inc.,
870 Badger Circle, Grafton, Wisconsin
53024, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
Drug
Tetrahydrocannabinols (7370) .....
Dihydromorphine (9145) ...............
Methylphenidate (1724) ................
Oxycodone (9193) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Schedule
I
I
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
E:\FR\FM\19JNN1.SGM
19JNN1
35311
Federal Register / Vol. 71, No. 117 / Monday, June 19, 2006 / Notices
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than August 18, 2006.
Dated: June 9, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–9508 Filed 6–16–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated January 11, 2006, and
published in the Federal Register on
January 23, 2006 (71 FR 3543), Cerilliant
Corporation, 811 Paloma Drive, Suite A,
Round Rock, Texas 78664, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the basic classes of controlled
substances listed in Schedules I and II:
jlentini on PROD1PC65 with NOTICES
Drug
Schedule
Cathinone (1235) ..........................
Methcathinone (1237) ..................
N-Ethylamphetamine (1475) ........
N,N-Dimethylamphetamine (1480)
Aminorex (1585) ...........................
4-Methylaminorex (cis isomer)
(1590).
Gamma
Hydroxybutyric
acid
(2010).
Methaqualone (2565) ...................
Alpha-Ethyltryptamine (7249) .......
Lysergic acid diethylamide (7315)
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
Mescaline (7381) ..........................
3,4,5-Trimethoxyamphetamine
(7390).
4-Bromo-2,5dimethoxyamphetamine (7391).
VerDate Aug<31>2005
16:46 Jun 16, 2006
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 208001
Drug
Schedule
4-Bromo-2,5dimethoxyphenethylamine
(7392).
4-Methyl-2,5dimethoxyamphetamine (7395).
2,5-Dimethoxyamphetamine
(7396).
2,5-Dimethoxy-4ethylamphetamine (7399).
3,4-Methylenedioxyamphetamine
(7400).
5-Methoxy-3,4methylenedioxyamphetamine
(7401).
N-Hydroxy-3,4methylendioxyamphetamine
(7402).
3,4-Methylendioxy-Nethylamphetamine (7404).
3,4Methylenedioxymethamphetamine (7405).
4-Methoxyamphetamine (7411) ...
Bufotenine (7433) .........................
Diethyltryptamine (7434) ..............
Dimethyltryptamine (7435) ...........
Psilocybin (7437) ..........................
Psilocyn (7438) .............................
Acetyldihydrocodeine (9051) ........
Benzylmorphine (9052) ................
Codeine-N-oxide (9053) ...............
Dihydromorphine (9145) ...............
Heroin (9200) ...............................
Hydromorphinol (9301) .................
Methyldihydromorphine (9304) .....
Morphine-N-oxide (9307) .............
Normorphine (9313) .....................
Pholcodine (9314) ........................
Acetylmethadol (9601) .................
Allylprodine (9602) .......................
Alphacetylmethadol except levoalphacetylmethadol (9603).
Alphameprodine (9604) ................
Alphamethadol (9605) ..................
Betacetylmethadol (9607) ............
Betameprodine (9608) ..................
Betamethadol (9609) ....................
Betaprodine (9611) .......................
Hydroxypethidine (9627) ..............
Noracymethadol (9633) ................
Norlevorphanol (9634) ..................
Normethadone (9635) ..................
Trimeperidine (9646) ....................
Phenomorphan (9647) .................
Para-Fluorofentanyl (9812) ..........
3-Methylfentanyl (9813) ................
Alpha-Methylfentanyl (9814) ........
Acetyl-alpha-methylfentanyl
(9815).
Beta-hydroxyfentanyl (9830) ........
Beta-hydroxy-3-methylfentanyl
(9831).
Alpha-Methylthiofentanyl (9832) ...
3-Methylthiofentanyl (9833) ..........
Thiofentanyl (9835) ......................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Phenmetrazine (1631) ..................
Methylphenidate (1724) ................
Amobarbital (2125) .......................
Pentobarbital (2270) .....................
Secobarbital (2315) ......................
Glutethimide (2550) ......................
Nabilone (7379) ............................
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
Drug
1-Phenylcyclohexylamine (7460)
Phencyclidine (7471) ....................
1Piperidinocyclohexanecarbonitrile (8603).
Alphaprodine (9010) .....................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Diphenoxylate (9170) ...................
Benzoylecgonine (9180) ...............
Ethylmorphine (9190) ...................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Levorphanol (9220) ......................
Isomethadone (9226) ...................
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Thebaine (9333) ...........................
Levo-alphacetylmethadol (9648) ..
Oxymorphone (9652) ...................
Noroxymorphone (9668) ..............
Racemethorphan (9732) ..............
Alfentanil (9737) ...........................
Sufentanil (9740) ..........................
Fentanyl (9801) ............................
Schedule
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances to make reference standards
which will be distributed to their
customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Cerilliant Corporation to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Cerilliant Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR 1301.33,
the above named company is granted
registration as a bulk manufacturer of
the basic classes of controlled
substances listed.
Dated: June 12, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–9504 Filed 6–16–06; 8:45 am]
BILLING CODE 4410–09–P
E:\FR\FM\19JNN1.SGM
19JNN1
]]>Agencies
[Federal Register Volume 71, Number 117 (Monday, June 19, 2006)]
[Notices]
[Pages 35310-35311]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-9508]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to section 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on May 11, 2005, Cedarburg
Pharmaceutical, Inc., 870 Badger Circle, Grafton, Wisconsin 53024, made
application by renewal to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of the basic classes of controlled
substances listed in Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)............... I
Dihydromorphine (9145)..................... I
Methylphenidate (1724)..................... II
Oxycodone (9193)........................... II
Hydromorphone (9150)....................... II
Hydrocodone (9193)......................... II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
[[Page 35311]]
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than August 18, 2006.
Dated: June 9, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-9508 Filed 6-16-06; 8:45 am]
BILLING CODE 4410-09-P
